These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
    Author: Mouridsen HT, Palshof T, Brahm M, Rahbek I.
    Journal: Cancer Treat Rep; 1977; 61(1):47-50. PubMed ID: 324620.
    Abstract:
    Fifty-one postmenopausal patients with advanced breast cancer were randomized to receive either cyclophosphamide given continuously or cyclophosphamide given continuously with methotrexate, 5-fluorouracil, vincristine, and prednisone given intermittently. The results with the multiple-drug therapy were significantly better than with the single-drug therapy, both with regard to percentage (63% versus 25%) and median duration (400 versus 210 days) of objective response. Toxicity was moderately increased with the combination as compared to the single-drug treatment.
    [Abstract] [Full Text] [Related] [New Search]